Johannes C Huber

No ORCID on file · 19 papers in corpus · active 1997-2011

Study types

  • article 13
  • review 4
  • other 2

Condition tags

  • endometriosis 13
  • mesh:D004715 11
  • dysmenorrhea 2
  • chronic_pelvic_pain 1
  • infertility 1
  • dyspareunia 1
article 2011
·doi:10.1055/s-0031-1300030

The influence of a combined estrogen-progestin regimen (Climodien) on noopsyche, thymopsyche, personality and psychophysiological measures of menopausal syndrome patients was investigated in a double-blind, placebo-controlled, comparative, …

article 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.06.070
article 2010
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2010.01.010
article 2010
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-8-85

BACKGROUND: Initial publications examining the hereditary aspects of endometriosis appeared in the early seventies and demonstrated an up to seven-fold risk for endometriosis in first-degree relatives of endometriosis patients. The aim was …

review 2008
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.9.13.2317

BACKGROUND: There is increasing awareness of the opportunity that many contraceptive interventions may provide for additional health benefits. However, treatment of medical problems with oral contraceptives (OCs) is often an 'off-label' pra…

article 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.02.006
article 2005
·doi:10.1097/01.gme.0000141760.98678.ed

OBJECTIVE: Genetic factors have been proposed as modulators of the timing of natural menopause. Single nucleotide polymorphisms (SNPs) of genes associated with thrombophilia and vascular homeostasis may interfere with ovarian function and t…

article 2005
Obstetrics and gynecology ·doi:10.1097/01.aog.0000185259.01648.41

OBJECTIVE: Genetic as well as hormonal factors are known to influence the development and clinical course of endometriosis. We aimed to investigate the association among 10 single nucleotide polymorphisms (SNPs) involved in the estrogen met…

review 2004
Pharmacogenomics ·doi:10.1517/phgs.5.1.57.25687

The number of reports investigating disease susceptibility based on the carriage of low-penetrance, high-frequency polymorphisms has steadily increased over the last years. Evidence based on meta-analyses of individual case-control studies …

other 2004
Wiener klinische Wochenschrift ·doi:10.1007/s00508-004-0296-5

BACKGROUND: Endometriosis is characterized by the presence of endometrium-like tissue outside the uterus. This condition causes painful periods, chronic pelvic pain, subfertility and a profound reduction in quality of life, especially durin…

article 2003
·doi:10.1016/s0306-4530(02)00032-x
review 2003
Drugs of today (Barcelona, Spain : 1998) ·doi:10.1358/dot.2003.39.12.799414

Endometriosis is a multifactorial disease affecting up to 15% of women of reproductive age. This condition is characterized by the presence and growth of endometrial cells outside the uterus. Susceptibility to endometriosis depends on compl…

article 2003
·doi:10.1046/j.1365-2869.2003.00356.x

Differences in sleep and awakening quality between 51 insomniac postmenopausal syndrome patients and normal controls were evaluated. In a subsequent double-blind, placebo-controlled, comparative, randomized, three-arm trial (Climodien 2/3 =…

article 2002
Journal of assisted reproduction and genetics ·doi:10.1023/a:1016062726783
article 2002
Fertility and Sterility ·doi:10.1016/s0015-0282(01)02984-3
article 2002
Human Reproduction ·doi:10.1093/humrep/17.2.373

Combined laparoscopic retrieval of immature oocytes and ovarian electrocautery represents a new management in patients with polycystic ovary syndrome (PCOS), one of the most prevalent endocrinopathies associated with anovulatory infertility…

other 2002
Journal of the Society for Gynecologic Investigation ·doi:10.1016/s1071-5576(02)00174-0

To explore whether having the mutant tumor necrosis factor (TNF)2 (G-308*A) and TNFA-A (G-238*A) alleles in the TNF-alpha gene promotor region is higher in women with endometriosis, we determined the respective genotype and allele frequenci…

article 2002
·doi:10.1177/107155760200900510
review 1997
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1997.tb11038.x

OBJECTIVE: To evaluate the literature on contraindications contained in pharmaceutical data sheets of five currently available oestrogen replacement preparations (HRT). These contraindications include cardiovascular disease, diabetes, liver…